For each of these diagnostic groups, the dimensional ratings revealed significant comorbidity that was not captured by the DSM-IV categorical diagnoses. For instance, among patients with schizophrenia, 10 percent had anxiety symptoms that were rated as “severe,” and 73 percent had symptoms of anxiety that were either “mild” or “moderate.” Yet only 6 percent had received a diagnosis of anxiety.
Psychiatric News is running a series of articles titled “DSM-5: Advancing Diagnostics” about proposed changes to the manual, including the dimensional measures that are being proposed. See Psychiatric News here and here.
(Image: Copyright kentoh/shutterstock.com)